Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone status in multiple sclerosis: beyond corticosteroids.

Sansin Tüzün1, Ayşe Altintaş, Ilhan Karacan

  • 1Department of Physical Medicine and Rehabilitation, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey. sansin@veezy.com

Multiple Sclerosis (Houndmills, Basingstoke, England)
|December 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome" [Multiple Sclerosis and Related Disorders 112 (2026) 107312].

Multiple sclerosis and related disorders·2026
Same author

[Secondary diabetes].

Ugeskrift for laeger·2026
Same author

Loading modulates monosynaptic transmission from spindle primary afferents to motoneurons in humans.

Experimental brain research·2026
Same author

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.

European journal of neurology·2026
Same author

A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome.

Multiple sclerosis and related disorders·2026
Same author

Pregnancy and lactation-associated osteoporosis: insights from an online self-reported patient survey.

Archives of osteoporosis·2026

Multiple sclerosis (MS) patients exhibit lower bone mineral density (BMD) compared to controls. Disease duration and disability significantly impact BMD in MS, independent of glucocorticoid use.

Area of Science:

  • Neurology
  • Orthopedics
  • Endocrinology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease.
  • Bone health is a growing concern in MS management.
  • Factors influencing bone mineral density (BMD) in MS require further investigation.

Purpose of the Study:

  • To identify factors affecting bone mineral density (BMD) in individuals with multiple sclerosis (MS).
  • To compare BMD between MS patients and a healthy control group.

Main Methods:

  • Cross-sectional study involving 65 MS patients and 72 controls.
  • Dual-energy X-ray absorptiometry (DXA) for measuring BMD at the lumbar spine and hip.
  • Assessment of serum vitamin D, parathyroid hormone, and bone turnover markers.

Related Experiment Videos

Main Results:

  • MS patients demonstrated significantly lower BMD across all measured sites compared to controls.
  • Disease duration and functional status correlated with femoral BMD in women with MS.
  • No significant correlation was found between glucocorticoid use and BMD.

Conclusions:

  • Bone mineral density is compromised in multiple sclerosis patients.
  • Disease duration and disability are key factors influencing BMD in MS.
  • Further research is needed to elucidate the mechanisms behind bone loss in MS.